Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk M Nettelbeck

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
International Journal of Cancer|September 4, 2007
Modulation of viability and maturation of human monocyte-derived dendritic cells by oncolytic adenovirusesStephan Schierer, Andrea Hesse, Ina Müller, et al.
Cancer Research|March 13, 2002
The flt-1 promoter for transcriptional targeting of teratocarcinomaGerd J Bauerschmitz, Dirk M Nettelbeck, Anna Kanerva, et al.
Molecular Cancer Therapeutics|April 14, 2004
Analyses of melanoma-targeted oncolytic adenoviruses with tyrosinase enhancer/promoter-driven E1A, E4, or both in submerged cells and organotypic culturesN Sanjib Banerjee, Angel A Rivera, Minghui Wang, et al.
Molecular Therapy. Methods & Clinical Development|April 19, 2016
Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic virusesGuy Ungerechts, Sascha Bossow, Barbara Leuchs, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 2014
Artificial riboswitches for gene expression and replication control of DNA and RNA virusesPatrick Ketzer, Johanna K Kaufmann, Sarah Engelhardt, et al.
Molecular Therapy. Oncology|January 19, 2026
Oncolytic adenoviruses encoding bispecific T cell engagers or a novel trispecific T cell engager for dual-targeting of c-MET and EGFRMartin A Boos, Oliver Seifert, Stefanie Sawall, et al.
Journal of Virology|July 13, 2012
Generation of an adenovirus-parvovirus chimera with enhanced oncolytic potentialNazim El-Andaloussi, Serena Bonifati, Johanna K Kaufmann, et al.
Human Gene Therapy|October 14, 2010
Selectivity and efficiency of late transgene expression by transcriptionally targeted oncolytic adenoviruses are dependent on the transgene insertion strategyChristina Quirin, Stanimira Rohmer, Inés Fernández-Ulibarri, et al.
International Journal of Cancer|November 18, 2003
Retargeting of adenoviral infection to melanoma: combining genetic ablation of native tropism with a recombinant bispecific single-chain diabody (scDb) adapter that binds to fiber knob and HMWMAADirk M Nettelbeck, Angel A Rivera, Jörg Kupsch, et al.
Cancer Gene Therapy|September 18, 2004
Employment of microarray analysis to characterize biologic differences associated with tropism-modified adenoviral vectors: utilization of non-native cellular entry pathwaysAndrea L Volk, Angel A Rivera, Grier P Page, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|September 4, 2007
Modulation of viability and maturation of human monocyte-derived dendritic cells by oncolytic adenovirusesStephan Schierer, Andrea Hesse, Ina Müller, et al.
Cancer Research|March 13, 2002
The flt-1 promoter for transcriptional targeting of teratocarcinomaGerd J Bauerschmitz, Dirk M Nettelbeck, Anna Kanerva, et al.
Molecular Cancer Therapeutics|April 14, 2004
Analyses of melanoma-targeted oncolytic adenoviruses with tyrosinase enhancer/promoter-driven E1A, E4, or both in submerged cells and organotypic culturesN Sanjib Banerjee, Angel A Rivera, Minghui Wang, et al.
Molecular Therapy. Methods & Clinical Development|April 19, 2016
Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic virusesGuy Ungerechts, Sascha Bossow, Barbara Leuchs, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 2014
Artificial riboswitches for gene expression and replication control of DNA and RNA virusesPatrick Ketzer, Johanna K Kaufmann, Sarah Engelhardt, et al.
Molecular Therapy. Oncology|January 19, 2026
Oncolytic adenoviruses encoding bispecific T cell engagers or a novel trispecific T cell engager for dual-targeting of c-MET and EGFRMartin A Boos, Oliver Seifert, Stefanie Sawall, et al.
Journal of Virology|July 13, 2012
Generation of an adenovirus-parvovirus chimera with enhanced oncolytic potentialNazim El-Andaloussi, Serena Bonifati, Johanna K Kaufmann, et al.
Human Gene Therapy|October 14, 2010
Selectivity and efficiency of late transgene expression by transcriptionally targeted oncolytic adenoviruses are dependent on the transgene insertion strategyChristina Quirin, Stanimira Rohmer, Inés Fernández-Ulibarri, et al.
International Journal of Cancer|November 18, 2003
Retargeting of adenoviral infection to melanoma: combining genetic ablation of native tropism with a recombinant bispecific single-chain diabody (scDb) adapter that binds to fiber knob and HMWMAADirk M Nettelbeck, Angel A Rivera, Jörg Kupsch, et al.
Cancer Gene Therapy|September 18, 2004
Employment of microarray analysis to characterize biologic differences associated with tropism-modified adenoviral vectors: utilization of non-native cellular entry pathwaysAndrea L Volk, Angel A Rivera, Grier P Page, et al.
Pageof 7